机构

• 合肥物质科学研究... [215]
• 上海药物研究所 [133]
• 自动化研究所 [116]
• 上海营养与健康研究... [52]
• 昆明动物研究所 [38]
• 大连化学物理研究所 [35]
• 更多

采集方式

• OAI收割 [929]
• iSwitch采集 [27]

内容类型

• 期刊论文 [895]
• 会议论文 [31]
• 学位论文 [28]
• 专利 [1]
• 专著章节/文集论文 [1]

发表日期

• 2024 [5]
• 2023 [35]
• 2022 [111]
• 2021 [123]
• 2020 [117]
• 2019 [90]
• 更多

学科主题

• Oncology [25]
• Biochemis... [15]
• Cell Biol... [12]
• Science & ... [9]
• Biotechnol... [5]
• Chemistry [5]
• 更多

筛选

浏览/检索结果: 共956条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress 期刊论文  OAI收割 PHARMACEUTICS, 2024, 卷号: 16, 期号: 2, 页码: 21 作者:  Cheng, Shigao;  Wang, Huiyuan;  Kang, Xuejia;  Zhang, Hui   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/04/09 osteosarcoma  suppressive immune environment  nanoparticles  immunotherapy   Robustly uncovering the heterogeneity of neurodegenerative disease by using data-driven subtyping in neuroimaging: A review 期刊论文  OAI收割 BRAIN RESEARCH, 2024, 卷号: 1823, 页码: 13 作者:  Chen, Pindong;  Zhang, Shirui;  Zhao, Kun;  Kang, Xiaopeng;  Rittman, Timothy   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/02/22 Neurodegenerative diseases  Alzheimer's disease  Heterogeneity  Subtype  Data-driven   A radiomics and genomics-derived model for predicting metastasis and prognosis in colorectal cancer 期刊论文  OAI收割 CARCINOGENESIS, 2024, 页码: 11 作者:  Li, Xue;  Wu, Meng;  Wu, Min;  Liu, Jie;  Song, Li   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/03/26 Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies 期刊论文  OAI收割 CELL, 2024, 卷号: 187, 期号: 1, 页码: 49 作者:  Liu, Qian;  Zhang, Jing;  Guo, Chenchen;  Wang, Mengcheng;  Wang, Chenfei   |  收藏  |  浏览/下载：5/0  |  提交时间：2024/02/27 Role of F-box proteins in human upper gastrointestinal tumors 期刊论文  OAI收割 BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 卷号: 1879, 期号: 1, 页码: 16 作者:  Zhang, Che;  Pan, Guangzhao;  Qin, Jiang-Jiang   |  收藏  |  浏览/下载：22/0  |  提交时间：2024/02/27 F-box protein  Upper gastrointestinal cancer  E3 ubiquitin ligase  Ubiquitin   Structure-based drug discovery of novel fused- pyrazolone carboxamide derivatives as potent and selective AXL inhibitors 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4918-4933 作者:  Fang, Feifei;  Dai, Yang;  Wang, Hao;  Ji, Yinchun;  Liang, Xuewu   |  收藏  |  浏览/下载：7/0  |  提交时间：2024/01/26 derivatives  Antitumor drug development  Potential AXL inhibitor  Antitumor activity  Structure-based drug design  Fused-pyrazolone carboxamide   Jin-Fu-An decoction manipulation of macrophage polarization via β-catenin (CTNNB1) synergizes with cisplatin in lung cancer 期刊论文  OAI收割 BIOMEDICINE & PHARMACOTHERAPY, 2023, 卷号: 168, 页码: 17 作者:  Tang, Yang;  Sun, Zhe;  Wu, Siqi;  Zhang, Chengyu;  Zhang, Yanling   |  收藏  |  浏览/下载：18/0  |  提交时间：2024/01/16 Lung cancer  Jin-Fu-An decoction  Tumor-associated macrophages  Macrophage polarization  beta-catenin  Infiltration of cytotoxic T cells   Tumor Mutation Burden-Related Histopathologic Features for Predicting Overall Survival in Gliomas Using Graph Deep Learning 期刊论文  OAI收割 AMERICAN JOURNAL OF PATHOLOGY, 2023, 卷号: 193, 期号: 12, 页码: 2111-2121 作者:  Sun, Caixia;  Luo, Tao;  Liu, Zhenyu;  Ge, Jia;  Shao, Lizhi   |  收藏  |  浏览/下载：4/0  |  提交时间：2024/02/22 TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage 期刊论文  OAI收割 CANCER MEDICINE, 2023, 页码: 14 作者:  Chang, Shuaikang;  Xiao, Wenqin;  Xie, Yongsheng;  Xu, Zhijian;  Li, Bo   |  收藏  |  浏览/下载：7/0  |  提交时间：2023/12/11 DNA damage  DSBs repair  myeloma  TI17  Trip13   Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L 期刊论文  OAI收割 CANCERS, 2023, 卷号: 15, 期号: 21, 页码: 28 作者:  Li, Xin;  Wu, Xiaowei;  Nie, Shenyou;  Zhao, Jidong;  Yao, Yuan   |  收藏  |  浏览/下载：7/0  |  提交时间：2023/12/19 MLL-rearranged leukemia  super elongation complexes  small-molecule inhibitor  protein-protein interaction  cancer therapeutics